-
Blog BLOG
-
Product Center BRAND DYNAMICS
-
Investor INVESTOR RELATIONS
-
Contact Us CONTACT
-
Supervise SUPERVISION
Russia's Ministry of Health approves the phase III clinical trial of the COVID-19 vaccine V-01 developed by CSPC Pharmaceutical Group
Published Time:
2021-11-11
Currently, the international multicenter, randomized, double-blind, placebo-controlled phase III clinical trial of V-01 in Pakistan and Malaysia is evaluating the protective efficacy, safety, and immunogenicity of V-01 as a booster dose in healthy adults aged 18 and above who have completed two doses of inactivated vaccine. Phase III clinical trials in the Philippines and Indonesia are also underway. The approval of this phase III clinical trial in Russia will further accelerate the development of V-01 and contribute Livzon's strength to the fight against the epidemic.
V-01 is an innovative novel coronavirus recombinant protein vaccine jointly developed by Livzon Mabpharm and the Institute of Biophysics, Chinese Academy of Sciences. V-01 was initiated in July 2020 and approved for clinical trials by the National Medical Products Administration of China in early 2021. The indication is for the prevention of diseases caused by novel coronavirus infection (COVID-19).
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
Sorry,当前栏目暂无内容!
您可以查看其他栏目或返回 首页
Sorry,The current column has no content!
You can view other columns or return Home